Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,864,178
  • Shares Outstanding, K 31,349
  • Annual Sales, $ 527,210 K
  • Annual Income, $ -58,130 K
  • 60-Month Beta 1.65
  • Price/Sales 13.04
  • Price/Cash Flow N/A
  • Price/Book 9.32
Trade GWPH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.81
  • Most Recent Earnings -0.08 on 02/16/21
  • Next Earnings Date 05/10/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 0.00%
  • Historical Volatility 2.12%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.02
  • Number of Estimates 2
  • High Estimate 0.12
  • Low Estimate -0.07
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +107.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
217.05 +0.88%
on 04/05/21
219.57 -0.28%
on 05/03/21
+1.70 (+0.78%)
since 04/01/21
3-Month
211.70 +3.43%
on 02/23/21
219.57 -0.28%
on 05/03/21
+5.05 (+2.36%)
since 02/04/21
52-Week
87.07 +151.49%
on 10/29/20
219.57 -0.28%
on 05/03/21
+114.68 (+109.97%)
since 05/04/20

Most Recent Stories

More News
Legal Marijuana Market Industry Analysis and Detailed Profiles of top Industry Players the COVID-19

Market Research Engine has published a new report titled as

APHA : 15.38 (-0.45%)
ACB.TO : 9.15 (+6.52%)
GWPH : 218.96 (-0.15%)
MRRCF : 0.0050 (-9.09%)
Cannabis Extraction Market Research Report with Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2020-2026

A cannabis extract is any oil-like substance that concentrates the chemical compounds like THC or CBD from the cannabis plant. A variety of methods exist for separating cannabinoids from plant material...

ACB.TO : 9.15 (+6.52%)
FMAX : N/A (unch)
GWPH : 218.96 (-0.15%)
MRRCF : 0.0050 (-9.09%)
Cannabis Extract Market Size, Share, Trends, Analysis and Forecast 2027

The Global is estimated to value over USD 25.9 billion by 2027 end at a CAGR of over 16.6% during the forecast period 2020 to 2027.

APHA : 15.38 (-0.45%)
ACB.TO : 9.15 (+6.52%)
GWPH : 218.96 (-0.15%)
MRRCF : 0.0050 (-9.09%)
Medical Cannabis Market Size, Share, Trends, Analysis and Forecast 2027

The Global is poised to value over USD 31 billion by 2027 end at a CAGR of over 24.2% during the forecast period 2020 to 2027.

APHA : 15.38 (-0.45%)
ACB.TO : 9.15 (+6.52%)
GWPH : 218.96 (-0.15%)
INSY : 0.29 (unch)
MJNA : 0.0303 (-0.98%)
Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of GW Pharmaceuticals, PLC In The Southern District Of California

, /PRNewswire/ -- Notice is hereby given that has filed a class action lawsuit in District Court for the Southern District of , , Docket No. 3:21-cv-01019, on behalf of holders of American Depositary...

JAZZ : 174.54 (+0.48%)
GWPRF : 17.0000 (+16.92%)
GWPH : 218.96 (-0.15%)
Legal Marijuana Market Analysis, Size, Regional Outlook, Competitive Strategies and Forecasts to 2027

Market Research Engine has published a new report titled as

APHA : 15.38 (-0.45%)
ACB.TO : 9.15 (+6.52%)
GWPH : 218.96 (-0.15%)
MRRCF : 0.0050 (-9.09%)
Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities

, /PRNewswire/ -- Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As researchers and scientists took closer looks...

NUMI.VN : 0.980 (+6.52%)
JAZZ : 174.54 (+0.48%)
TRYP.CN : 0.620 (+5.08%)
TRYPF : 0.4850 (+2.11%)
GWPH : 218.96 (-0.15%)
SEEL : 2.38 (+3.48%)
Medical Marijuana Market 2020 Industry Size, Growth, Trends, Segments and Cost Structure Analysis Research Report 2028

Research Nester published a report titled  which delivers a detailed overview of the medical marijuana market in terms of market segmentation by end- user, by product, by application, and by region.

ACB.TO : 9.15 (+6.52%)
APHA : 15.38 (-0.45%)
TLRY : 16.01 (+25.77%)
GWPH : 218.96 (-0.15%)
ACB : 7.29 (+6.58%)
MRRCF : 0.0050 (-9.09%)
LXRP : 0.2249 (-10.68%)
CNABQ : 0.0080 (+11.11%)
Cannabis Cultivation Market Size, Share, Trends, Analysis and Forecast 2027

The Global is estimated to value over USD 98 billion by 2027 end at a CAGR of over 18% during the forecast period 2020 to 2027.

APHA : 15.38 (-0.45%)
ACB.TO : 9.15 (+6.52%)
GWPH : 218.96 (-0.15%)
Medical Cannabis Market to Incur Considerable Upsurge During 2020-2027

Medicinal Cannabis Market to Surpass US$ 31,248.8 Million by 2027 – Coherent Market Insights

APHA : 15.38 (-0.45%)
ACB.TO : 9.15 (+6.52%)
GWPH : 218.96 (-0.15%)
INSY : 0.29 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

3rd Resistance Point 220.41
2nd Resistance Point 219.97
1st Resistance Point 219.47
Last Price 218.96
1st Support Level 218.53
2nd Support Level 218.09
3rd Support Level 217.59

See More

52-Week High 219.57
Last Price 218.96
Fibonacci 61.8% 168.95
Fibonacci 50% 153.32
Fibonacci 38.2% 137.68
52-Week Low 87.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar